Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'Amgen'  -  Page 45
Latest

Tri-county stocks fall after Britain votes to exit EU

By   /  Friday, June 24th, 2016  /  Latest news, Tri-County Public Companies  /  Comments Off on Tri-county stocks fall after Britain votes to exit EU

Stock prices for many companies headquartered in the Tri-Counties fell June 24 as investors reacted to Britain’s vote to leave the European Union. Thousand Oaks-based biotech giant Amgen dropped $5.82 or 3.82 percent. Two other companies based in Thousand Oaks, Teledyne and Inphi, saw stock prices decline $5.72 or 5.66 percent and $3.44 or 10.52 Read More →

Read More →
Latest

SEC warns firms about using non-GAAP numbers

By   /  Friday, June 10th, 2016  /  Earnings, Latest news  /  Comments Off on SEC warns firms about using non-GAAP numbers

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s new drug for migraines shows promise

By   /  Thursday, June 9th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen’s new drug for migraines shows promise

Thousand Oaks-based Amgen said a drug being developed in collaboration with Novartis showed promising results in providing relief for patients suffering from chronic migraines. The Phase 2 clinical trial met benchmarks for migraine reduction at two levels of dosage and with limited side effects. “Migraine is the sixth-leading cause of disability worldwide. Three to seven Read More →

Read More →
Latest

Amgen subsidiary discovers rare gene that could reduce heart attack risk

By   /  Thursday, May 19th, 2016  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen subsidiary discovers rare gene that could reduce heart attack risk

An Amgen subsidiary may have found a rare gene that could drastically reduce the risk of heart attacks in the future. DeCode Genetics, an Iceland-based subsidiary of Thousand Oaks biotech giant Amgen, uncovered a rare and unknown genetic variation in some people that could reduce the risk of heart attacks and lower cholesterol. The variant Read More →

Read More →
Latest

NBC locks up Amgen Tour of California coverage through 2019

By   /  Friday, May 13th, 2016  /  Latest news  /  Comments Off on NBC locks up Amgen Tour of California coverage through 2019

NBC Sports and AEG Worldwide agreed to a three-year media rights extension of the Amgen Tour of California on May 12. NBC started televising the Tour of California in 2007 during the second year of the weeklong bicycle race. With the extension, NBC Sports Group will retain U.S. media rights on all platforms and will Read More →

Read More →
Latest

Amgen exceeds Wall Street expectations for first quarter earnings

By   /  Thursday, April 28th, 2016  /  Central Coast Health Watch, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Amgen exceeds Wall Street expectations for first quarter earnings

Amgen blew away Wall Street expectations and raised its 2016 guidance when it released first quarter earnings April 28. The Thousand Oaks biotech giant had profits of $2.2 billion, up from $1.91 billion during the same quarter last year. Revenues of $5.53 billion were also up from $5 billion in 2015 and surpassed analyst estimates Read More →

Read More →
Latest

CSUCI may add engineering program in fall

By   /  Friday, April 22nd, 2016  /  Education, Latest news  /  Comments Off on CSUCI may add engineering program in fall

Retiring CSU Channel Islands President Richard Rush said April 21 an engineering program could be launched at the school this fall. Rush said he hopes to make an official announcement in two weeks. He made the surprise announcement at the CSUCI Business and Technology Partnership Leadership Dinner at the Crowne Plaza Hotel in Ventura. Last Read More →

Read More →